Tackling challenging targets. De-risking drug discovery.
Tackling challenging targets. De-risking drug discovery.
Drug targets can be elusive. True biology of challenging targets can only be represented within their native cell environment. CellarisBio tackles challenging targets with unprecedented Micro-Tag™ cell target engagement platform.
Enhance the breadth of your assays with highly sensitive cellular assays, from low nano-molar to high micro-molar levels.
Upgrade your drug discovery data with real-time cell target engagement data. Reveal in-cell kinetics of drug-target engagement.
Empower your drug discovery program with de novo discovery using DNA-Encoded Libraries (DELs) - all in the cell.
MICRO-TAG™ platform uses the next-gen cell target engagement technology. It enables interrogation of targets without interfering with folding, localization and function.
Our platform has been tested and validated for a number of challenging target families, such as transcription factors, together with multiple therapeutic modalities.
Leverage the platform for challenging drug target. De-risk and accelerate drug discovery programs from discovery of candidates to validation, ranking and MoA analysis.
San Diego, California
Reserve your seat! Be the first to hear when the program is out!
Copyright © 2024 CellarisBio - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.
Are you developing a future targeted therapy?
Are you working on a hot yet challenging drug target?
The Challenging Target Award program is designed for life science companies to de-risk & accelerate top-in-class drug discovery programs.